CancerCare Manitoba Foundation

1160-675 McDermot Ave
Winnipeg, MB R3E 0V9
President & CEO: Patti Smith
Board Chair: Jeoff Chipman

Charitable Reg. #:88688 6746 RR0001

STAR RATING

Ci's Star Rating is calculated based on the following independent metrics:

🔓
Unlock Charity Ratings

✔+

FINANCIAL TRANSPARENCY

Audited financial statements for current and previous years available on the charity’s website.

B-

RESULTS REPORTING

Grade based on the charity's public reporting of the work it does and the results it achieves.

n/r

DEMONSTRATED IMPACT

The demonstrated impact per dollar Ci calculates from available program information.

NEED FOR FUNDING

Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.

78%

CENTS TO THE CAUSE

For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 78 cents are available for programs.



My anchor

OVERVIEW

About CancerCare Manitoba Foundation:

Founded in 1997, CancerCare Manitoba Foundation (CCMF) solely fundraises for CancerCare Manitoba (CCMB), Manitoba's provincially mandated cancer agency. Funds raised by CCMF for CCMB cover cancer and blood programs that are not funded by the government. Every year, almost 3,000 Manitoban women are diagnosed with cancer, and almost 800 Manitoban men are diagnosed with prostate cancer. Both CCMF and CCMB share a vision of eradicating cancer.

In F2020, CancerCare Manitoba Foundation provided $6.9m in funding (including $0.6m in deferred grants) for CCMB's strategic projects. CCMF funds programs including Research and Education; Patient Care (Support and Training); Clinical Trials; and Prevention, Risk Reduction, and Awareness.

Research and Education: In F2020, CancerCare Manitoba Foundation directed 59% of annual program funds to Research and Education. This program includes research projects in areas such as radiation treatments, genetics, and cancer and blood disorders. In F2020, CCMF funded CCMB's Tumour Bank, which is a storage hub for tissue samples. It has also supported 37 hematologists, 21 senior scientists, 18 radiation oncologists, 23 surgical oncologists, six pediatric oncologists, and seven urologists at CCMB. Regarding equipment purchases, a highlight in F2020 was the purchase of a Calypso machine. The machine tracks cancer cells to limit radiation damage to patients' other organs.

Patient Care (Support and Training): This program accounts for 22% of program spending in F2020. The charity describes this program as offering far-reaching patient programs, services, and initiatives. It includes various services for cancer patients such as yoga classes and restorative nipple tattooing post-breast cancer surgery.

Clinical Trials: Funding for clinical trials represents 14% of CCMF's program spending. In F2020, two categories of trials were funded. These trials include adult, pediatric, and blood & marrow transplant trials as well as clinical trials at Western Manitoba Cancer Centre, Brandon.

Prevention, Risk Reduction, and Awareness: This program was 5% of program spending. General information on decreasing one's risk of cancer is provided on CCMF's website. Over 350 community events were held in F2020.

My anchor

Results and Impact

CancerCare Manitoba Foundation's new Calypso machine is the first of its kind in Canada. It provides safer radiation treatment by tracking the frequency of the cancer cells being radiated to avoid unnecessary organ damage. Typical treatment for prostate cancer would require patients to go into a hospital for low-dose radiation once a day for seven weeks. Calypso substantially reduces treatment frequency and duration. It requires patients to go into a hospital once every week for five weeks.

Dr. Versha Banerji, one of the doctors whose Harvard education was sponsored by CancerCare Manitoba, won the Research Manitoba New Investigator Award for her research study Resetting the Clock: Modifying Circadian Rhythm in CLL. She is now conducting research at CCMB on the relationship between Chronic Lymphocytic Leukemia and the circadian rhythm.

Charity Intelligence highlights these key results. They may not be a complete representation of CancerCare Manitoba Foundation's results. Charity Intelligence has not assessed CCMF on impact. This shows as n/r, meaning not rated.

My anchor

Finances

CancerCare Manitoba Foundation had $11.9m in donations and special events revenues in F2020. Administrative costs are 7% of revenues and fundraising costs are 15% of donations. For every dollar donated, 78 cents go to the cause. This falls within Ci’s reasonable range for overhead spending.

CCMF’s funding reserves total $64.7m in F2020, of which $11.4m are donor-endowed. Excluding CCMF’s endowment fund, funding reserves can cover granting activities for 8.4 years. Program coverage in F2020 was almost double that in F2019 as CCMF made a total of $19.9m on the sale of some of its properties. The charity has made $14.4m in grant commitments to CCMB over the next two years including $5.8m in outstanding grant commitments in F2020.

The Foundation holds $39.1m in investments as of F2020, of which 61% are held in equities. Investment income of ($2.8m) in F2020, including unrealized losses of $3.6m, represents a -6.6% return on investment. Average return on investment over the past five years is 2.7%.

This charity report is an update that has been sent to CancerCare Manitoba Foundation for review. Changes and edits may be forthcoming.

Updated on July 13, 2021 by Rachel Leteta.

 

Financial Review


Financial Ratios

Fiscal year ending March
202020192018
Administrative costs as % of revenues 7.4%10.8%14.1%
Fundraising costs as % of donations 14.9%17.5%17.3%
Total overhead spending 22.3%28.3%31.4%
Program cost coverage (%) 837.3%337.8%1,146.7%

Summary Financial Statements

All figures in $000s
202020192018
Donations 6,8264,7884,650
Government funding 1,2230174
Special events 5,0545,0304,414
Investment income (2,794)2,9811,307
Other income 1,598156283
Total revenues 11,90812,95510,828
Grants 6,9329,5423,253
Administrative costs 1,0851,0731,341
Fundraising costs 1,7671,7191,569
Total spending 9,78412,3336,163
Cash flow from operations 2,1246224,665
Capital spending (19,862)01
Funding reserves 64,65842,57142,463

Note: Ci included unrealized gains in investment income, affecting revenues by ($3.6m) in F2020, $1.0m in F2019, and $442k in F2018. Total administrative costs in Ci’s financial analysis include general administrative expenses and marketing and communication expenses. Instead of reporting net events revenues in revenues, Ci reports events revenues under revenues and events expenses under expenses. Government funding reported in the charity's T3010 filing of $1.2m in F2020, and $174k in F2018 was taken out of Canadian donations and reported separately as such. Other income in F2020 includes some portion of the proceeds on the sale of properties; however, the charity has not disclosed the amount of these proceeds.  

Salary Information

Full-time staff: 19

Avg. Compensation: $89,558

Top 10 staff salary range:

$350k +
0
$300k - $350k
0
$250k - $300k
0
$200k - $250k
1
$160k - $200k
0
$120k - $160k
2
$80k - $120k
1
$40k - $80k
6
< $40k
0

Information from most recent CRA Charities Directorate filings for F2020

My anchor

Comments & Contact

Comments added by the Charity:

No comments have been added by the charity.

Charity Contact

Website: www.cancercarefdn.mb.ca
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 204-787-4143

Print